Héctor Perez‐Montoyo
Ability Pharmaceuticals (Spain)
ORCID: 0000-0002-9540-9604MedicineBiochemistry, Genetics and Molecular Biology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 1 paper. Top paper: “RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer”.
RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer
N/A
21 citations
Eva M. Trinidad, Gema Pérez-Chacón, Mansour Alsaleem, María Jiménez, María José Jiménez‐Santos +21 more